Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aging
89%
Senescence
83%
Werner Syndrome
76%
Fibroblasts
73%
Cellular Senescence
65%
Senescent Cells
58%
Aging Process
51%
Resveratrol
39%
Replicative Senescence
38%
Aging Mechanism
34%
Human Aging
30%
Later Life
29%
Cell Senescence
27%
Telomere
23%
Silent Information Regulator 1 (SIRT1)
23%
Human Fibroblasts
22%
Telomerase
20%
Drug Discovery
19%
Therapeutic Potential
19%
Keratocytes
19%
Population Aging
18%
Hepatotoxic
18%
HepG2 Cells
18%
Resveratrol Derivatives
18%
Camptothecin
18%
Splicing Factor
18%
Growth Arrest
17%
Age-related Illnesses
16%
Aging Research
16%
Cellular Aging
15%
Research Discovery
15%
Healthspan
15%
Biogerontology
14%
Small Molecules
14%
Primary Fibroblasts
13%
Aging Rate
13%
Senescence-associated Secretory Phenotype
13%
Humanized Liver
12%
Late Passage
12%
Green Theory
12%
Human Life
12%
Keratoprosthesis
12%
Healthy Aging
12%
Premature Senescence
12%
Knockdown
12%
Signaling Pathway
11%
P38 MAP Kinase
11%
T Cells
11%
Human Telomerase Reverse Transcriptase (hTERT)
11%
Comets
10%
Biochemistry, Genetics and Molecular Biology
Fibroblast
100%
Werner Syndrome
72%
Lifespan
48%
Telomere
34%
Human Aging
23%
Telomerase
21%
Resveratrol
21%
P53
20%
Signal Transduction
18%
Small Molecule
18%
Splicing Factor
18%
Progeria
18%
Molecular Mechanism
18%
Cell Cycle
17%
P38 Mitogen-Activated Protein Kinases
16%
Genetics
16%
Helicase
13%
Normal Human
12%
Keratinocyte
12%
T Cell
11%
Sirtuin1
10%
Upregulation
9%
DNA Damage
9%
Somatic Cell
9%
Biological Phenomena and Functions Concerning the Entire Organism
9%
ETV6
9%
Exonuclease
9%
FOXO1
9%
Drosophila Melanogaster
9%
Artificial Intelligence
9%
Transcriptome
9%
Isoform
9%
Genome Instability
9%
Cyclin D1
9%
Telomerase Reverse Transcriptase
9%
Sheep
9%
Metabolomics
9%
Chromosome
9%
Mutation Accumulation
9%
Revertant
9%
RecQ Helicase
8%
RNA Splicing
7%
Biogerontology
7%
Protein Kinase B
7%
Genetic Disorder
7%
DNA Topoisomerase
6%
Topoisomerase
6%
Wild Type
6%
Loss of Function Mutation
6%
Drug Development
6%